Evidence map›Paper›PMID 38047703›Full record

ArticleMicrobiology spectrum2024

Efficacy of EHEC gold nanoparticle vaccines evaluated with the Shiga toxin-producing

Sarah Bowser, Angela Melton-Celsa, Itziar Chapartegui-González, Alfredo G Torres

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sarah BowserDepartment of Microbiology and Immunology, The University of Texas Medical Branch at Galveston , Galveston, Texas, USA.
Angela Melton-CelsaDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences , Bethesda, Maryland, USA.
Itziar Chapartegui-GonzálezDepartment of Microbiology and Immunology, The University of Texas Medical Branch at Galveston , Galveston, Texas, USA.ORCID 0000-0001-7878-4499
Alfredo G TorresDepartment of Microbiology and Immunology, The University of Texas Medical Branch at Galveston , Galveston, Texas, USA.ORCID 0000-0001-6450-0643
The University of Texas Medical Branch at Galveston · USUniformed Services University of the Health Sciences · US

Funding

Developing effective nanovaccines against pathogenic Escherichia coliR21AI155844 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TORRES, ALFREDO G · 2021 to 2022
$435k
NIAID NIH HHS R21 AI155844NIAID NIH HHS UTMB SIVS
6 · The paper itself

Abstract

importanceEnterohemorrhagic

Indexed as

Enterohemorrhagic Escherichia coliEscherichia coli InfectionsMetal NanoparticlesAnimalsChildCitrobacter rodentiumGoldHumansMiceNanovaccinesShiga ToxinGoldNanovaccinesShiga ToxinCitrobacter rodentiumEHEChemolytic uremic syndromenanovaccinesShiga toxin

Identifiers

PMID38047703
PMCPMC10783022
OpenAlexW4389298752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.